Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
British Journal of Haematology
|
July 25, 2012
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma
Alessandro Martino, Daniele Campa, Krzysztof Jamroziak, et al.
Haematologica
|
March 19, 2026
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone
Carmine Liberatore, Alfonso Piciocchi, Donatella Vincelli, et al.
Nature Communications
|
December 10, 2015
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients
Elad Ziv, Eric Dean, Donglei Hu, et al.
European Journal of Haematology
|
January 15, 2026
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations
Alessandro Corso, Monia Marchetti, Monica Galli, et al.
Nature Communications
|
July 23, 2015
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients
Elad Ziv, Eric Dean, Donglei Hu, et al.
International Journal of Cancer
|
July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length
Daniele Campa, Alessandro Martino, Judit Varkonyi, et al.
European Journal of Human Genetics : EJHG
|
November 30, 2021
A polygenic risk score for multiple myeloma risk prediction
Federico Canzian, Chiara Piredda, Angelica Macauda, et al.
Haematologica
|
April 30, 2025
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients
Gregorio Barilà, Angela Grassi, Concetta Conticello, et al.
Leukemia & Lymphoma
|
January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study
Daniele Campa, Alessandro Martino, Angelica Macauda, et al.
Blood Cancer Journal
|
April 15, 2021
Genetically determined telomere length and multiple myeloma risk and outcome
Matteo Giaccherini, Angelica Macauda, Enrico Orciuolo, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
British Journal of Haematology
|
July 25, 2012
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma
Alessandro Martino, Daniele Campa, Krzysztof Jamroziak, et al.
Haematologica
|
March 19, 2026
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone
Carmine Liberatore, Alfonso Piciocchi, Donatella Vincelli, et al.
Nature Communications
|
December 10, 2015
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients
Elad Ziv, Eric Dean, Donglei Hu, et al.
European Journal of Haematology
|
January 15, 2026
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations
Alessandro Corso, Monia Marchetti, Monica Galli, et al.
Nature Communications
|
July 23, 2015
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients
Elad Ziv, Eric Dean, Donglei Hu, et al.
International Journal of Cancer
|
July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length
Daniele Campa, Alessandro Martino, Judit Varkonyi, et al.
European Journal of Human Genetics : EJHG
|
November 30, 2021
A polygenic risk score for multiple myeloma risk prediction
Federico Canzian, Chiara Piredda, Angelica Macauda, et al.
Haematologica
|
April 30, 2025
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients
Gregorio Barilà, Angela Grassi, Concetta Conticello, et al.
Leukemia & Lymphoma
|
January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study
Daniele Campa, Alessandro Martino, Angelica Macauda, et al.
Blood Cancer Journal
|
April 15, 2021
Genetically determined telomere length and multiple myeloma risk and outcome
Matteo Giaccherini, Angelica Macauda, Enrico Orciuolo, et al.
Page
of 14